Watch PRVA. Know when insiders buy.
One email the day a filing lands. Free.
PRVA
Privia Health Group, Inc.
19.71
+0.32 +1.65%
USD · close Sep 25
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
42
WATCH · shorts 42
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $2.5BP/E 93.9DIV YIELD —FCF YIELD —REV TTM —NET INCOME $28.1M +89.5%NET CASH —52W 19.10 – 28.10SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | $11.8M | $9M | +236.7% | 0.07 | $1.1M | — | — | Aug 6 |
| Q1 2026 · Mar 31 | — | — | — | $7.4M | $3.1M | −27.4% | 0.02 | −$49.5M | — | — | May 7 |
| Q4 2025 · Dec 31derived | — | — | — | $11.3M | $9.2M | +108.0% | 0.07 | $127.5M | — | — | Feb 27 |
| Q3 2025 · Sep 30 | — | — | — | $14.4M | $6.9M | +94.1% | 0.05 | $52M | — | — | Nov 6 |
| Q2 2025 · Jun 30 | — | — | — | $3.3M | $2.7M | −22.5% | 0.02 | $8M | — | — | Aug 6 |
| Q1 2025 · Mar 31 | — | — | — | $5.2M | $4.2M | +41.4% | 0.03 | −$24.1M | — | — | May 7 |
| Q4 2024 · Dec 31derived | — | — | — | $5.2M | $4.4M | +55.0% | 0.03 | $74.8M | — | — | Feb 27 |
| Q3 2024 · Sep 30 | — | — | — | $5.8M | $3.5M | −37.4% | 0.03 | $33.2M | — | — | Nov 6 |
| Q2 2024 · Jun 30 | — | — | — | $5.1M | $3.5M | — | 0.03 | $34.5M | — | — | Aug 7 |
| Q1 2024 · Mar 31 | — | — | — | $823K | $3M | — | 0.02 | −$33.1M | — | — | May 8 |
| Q4 2023 · Dec 31derived | — | — | — | $1.4M | $2.8M | — | 0.03 | $64.1M | $23K | $64.1M | Feb 27 |
| Q3 2023 · Sep 30 | — | — | — | $5.5M | $5.6M | — | 0.05 | $22.5M | $18K | $22.4M | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | $34.2M | $22.9M | — | 0.18 | $163.4M | — | — | — | — |
| FY2024 · to Dec 31 | — | — | $17M | $14.4M | — | 0.11 | $109.3M | — | — | — | — |
| FY2023 · to Dec 31 | — | — | $20.6M | $23.1M | — | 0.19 | $80.8M | $113K | $80.7M | — | — |
| FY2022 · to Dec 31 | — | — | −$19.1M | −$8.6M | — | -0.08 | $47.2M | $104K | $47.1M | — | — |
| FY2021 · to Dec 31 | — | — | −$217.4M | −$188.2M | — | -1.83 | $55.1M | $547K | $54.5M | — | — |
| FY2020 · to Dec 31 | — | — | $25.4M | $31.2M | — | 0.33 | $38.9M | $380K | $38.5M | — | — |
Every number comes from Privia Health Group, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.